Literature DB >> 16950269

Mechanisms of airway hyperresponsiveness.

Donald W Cockcroft1, Beth E Davis.   

Abstract

Airway hyperresponsiveness (AHR) to direct (histamine and methacholine) and indirect (exercise, cold air, hyperventilation, AMP) challenges is a universal and defining feature of asthma. One component of AHR is transient or inducible and occurs after allergen exposure, for example, and improves occasionally rapidly after inhaled corticosteroids or environmental control. This transient airway hyperresponsiveness is more marked to the indirect stimuli. There are convincing data linking this component of AHR to airway inflammation; however, the precise mechanisms linking airway inflammation and hyperresponsiveness of the airway smooth muscle are not clear. The other component of AHR is more persistent and is relatively refractory to environmental control and inhaled corticosteroids. This is likely secondary to structural airway changes, which are collectively referred to as airway remodeling, and which are a result of the chronic (rather than the acute) effects of airway inflammation. This persistent AHR is best reflected by airway hyperresponsiveness to direct stimuli such as methacholine. The mechanisms are also uncertain, but reduced airway caliber, increased airway wall thickness, increased airway smooth muscle mass, and perhaps contractility likely all play a role.

Entities:  

Mesh:

Year:  2006        PMID: 16950269     DOI: 10.1016/j.jaci.2006.07.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  96 in total

1.  Natural killer T cells are dispensable in the development of allergen-induced airway hyperresponsiveness, inflammation and remodelling in a mouse model of chronic asthma.

Authors:  Y-I Koh; J-U Shim; J-H Lee; I-J Chung; J-J Min; J H Rhee; H C Lee; D H Chung; J-O Wi
Journal:  Clin Exp Immunol       Date:  2010-04-29       Impact factor: 4.330

2.  HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts.

Authors:  Changchun Hou; Jinliang Kong; Yue Liang; Hong Huang; Hanchun Wen; Xiaowen Zheng; Lihong Wu; Yiqiang Chen
Journal:  Cell Mol Immunol       Date:  2014-08-25       Impact factor: 11.530

3.  Hesperidin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.

Authors:  Dajun Wei; Xinxin Ci; Xiao Chu; Miaomiao Wei; Shucheng Hua; Xuming Deng
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

Review 4.  Adenosine receptors and asthma.

Authors:  Constance N Wilson; Ahmed Nadeem; Domenico Spina; Rachel Brown; Clive P Page; S Jamal Mustafa
Journal:  Handb Exp Pharmacol       Date:  2009

5.  Fluticasone/formoterol association favors long-lasting decrease in bronchial reactivity to methacholine and weekly PEF variability.

Authors:  Sara Cortese; Alessia Gatta; Loredana Della Valle; Rocco Mangifesta; Luca Di Giampaolo; Enrico Cavallucci; Claudia Petrarca; Roberto Paganelli; Mario Di Gioacchino
Journal:  Int J Immunopathol Pharmacol       Date:  2016-06-07       Impact factor: 3.219

Review 6.  Immune Homeostasis: Effects of Chinese Herbal Formulae and Herb-Derived Compounds on Allergic Asthma in Different Experimental Models.

Authors:  Lu Liu; Lin-Peng Wang; Shan He; Yan Ma
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

7.  31st g. Heiner sell lectureship: secondary medical consequences of spinal cord injury.

Authors:  William A Bauman; Mark A Korsten; Miroslav Radulovic; Gregory J Schilero; Jill M Wecht; Ann M Spungen
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

8.  Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma.

Authors:  Dasom Kim; Jaclyn W McAlees; Lindsay J Bischoff; Davinder Kaur; Lauren K Houshel; Jerilyn Gray; Julie Hargis; Xenia Davis; Paul L Dudas; Hitesh Deshmukh; Ian P Lewkowich
Journal:  Clin Exp Allergy       Date:  2018-11-29       Impact factor: 5.018

9.  Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.

Authors:  Brijeshkumar Patel; Nilesh Gupta; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2014-06-17       Impact factor: 4.200

10.  Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory cell accumulation in mouse model of asthma.

Authors:  Berislav Bosnjak; Vanesa Ivetić Tkalcević; Koraljka Durić; Daniela Belamarić; Snjezana Cuzić; Zeljko Ferencić; Karmen Brajsa; Ines Glojnarić; Roberto Antolović; Boska Hrvacić
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.